Hiroki Komatsuda

Department Of Otolaryngology Head & Neck Surgery
Asahikawa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Combined positive score using 28-8 predicts nivolumab efficacy in HNSCC.

Combined positive score using 28-8 predicts nivolumab efficacy in HNSCC.

Journal: Oral oncology

Published: March 22, 2026

M1C is a druggable target for NSCLC KRAS G12C mutant tumors resistant to KRAS inhibitors.

M1C is a druggable target for NSCLC KRAS G12C mutant tumors resistant to KRAS inhibitors.

Journal: Oncogene

Published: March 05, 2026

Peptide-Reactive T-cell Response as a Novel Biomarker in Patients with Head and Neck Cancer Treated with Anti-PD-1 Antibody.

Peptide-Reactive T-cell Response as a Novel Biomarker in Patients with Head and Neck Cancer Treated with Anti-PD-1 Antibody.

Journal: Cancer research communications

Published: December 16, 2025

Combined European and Japanese criteria to diagnose eosinophilic chronic rhinosinusitis.

Combined European and Japanese criteria to diagnose eosinophilic chronic rhinosinusitis.

Journal: Rhinology

Published: July 29, 2025

ROR1 as an Immunotherapeutic Target for Inducing Antitumor Helper T Cell Responses Against Head and Neck Squamous Cell Carcinoma.

ROR1 as an Immunotherapeutic Target for Inducing Antitumor Helper T Cell Responses Against Head and Neck Squamous Cell Carcinoma.

Journal: Cancers

Published: June 09, 2025

Mixing it up: boosting responses with immunotherapy combinations.

Mixing it up: boosting responses with immunotherapy combinations.

Journal: Trends in cancer

Published: April 10, 2025

Tumor-promoting function of paternally expressed gene 10 and its immunogenicity in inducing anti-tumor helper T cells in head and neck squamous cell carcinoma.

Tumor-promoting function of paternally expressed gene 10 and its immunogenicity in inducing anti-tumor helper T cells in head and neck squamous cell carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: March 18, 2025

Differences in PD-L1, PD-L2, and EGFR Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective Study.

Differences in PD-L1, PD-L2, and EGFR Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective Study.

Journal: Head & neck

Published: February 03, 2025

Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer.

Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer.

Journal: Cancers

Published: July 30, 2024

Comparative outcomes of video-assisted thyroidectomy and traditional open surgery: a 5-year analysis of a single center experience.

Comparative outcomes of video-assisted thyroidectomy and traditional open surgery: a 5-year analysis of a single center experience.

Journal: Brazilian journal of otorhinolaryngology

Published: July 17, 2024

A comparison of the clinical efficacy of tonsillectomy with steroid pulse therapy and tonsillectomy therapy alone for patients with immunoglobulin A nephropathy: a retrospective observational study.

A comparison of the clinical efficacy of tonsillectomy with steroid pulse therapy and tonsillectomy therapy alone for patients with immunoglobulin A nephropathy: a retrospective observational study.

Journal: Clinical and experimental nephrology

Published: April 02, 2024

Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers.

Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers.

Journal: Cancers

Published: February 26, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026